A few drugs approved from Phase 2 - Kyprolis -
Post# of 145246
![](/assets/46931549/no_avatar_available_thumb.jpg)
Kyprolis - 10 months after BLA submission, accelerated approval, no priority review
crizotinib - 7 months after BLA submission. accelerated approval, priority review
atezolizumab - 6 months from BLA submission, accelerated approval, priority review
There have been over 30 cancer drugs approved based on Phase 2 data.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)